CDEK
← All organizations

Serono

For profitContributed to NME

Also known as: SERONO | Serono GmbH | SERONO INC | Serono Nordic | Serono Pharmaceutical Limited | Serono Singapore | Serono Singapore Ltd, an affiliate of Merck Serono SA, Singapore

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Sep 1, 2002

First marketed drug

Aug 22, 1975

First NDA

Jul 30, 1976

Last known activity

Mar 1, 2006

Acquired by Merck KGaA → Merck Serono on Jan 1, 2006

Timeline

1900s

  1. Jan 1, 1906

    Serono— Founded

1970s

  1. Aug 22, 1975

    lutropin alpha— NDA Secondary Org

  2. Jul 30, 1976

    somatropin— NDA Organization

1990s

  1. Jan 1, 1994

    Sorebio— Acquired

  2. Jan 1, 1997

    Interpharm— Acquired

2000s

  1. Jan 1, 2002

    Genset— Acquired

  2. Mar 7, 2002

    interferon beta-1b— Marketing Organization

  3. Jan 1, 2006

    Merck KGaA— Acquired By

  4. Jan 1, 2006

    Merck Serono— Now

Drugs by trial phase (7 distinct, 5 trials)

Indications

Approved for

Studied for

Marketed drugs (7)

Subsidiaries (3 direct, 3 total across the full acquisition tree)

Recent trials (5)

Details

Founded
Geneva, CH Jan 1, 1906
First NDA
Jul 30, 1976
Last known activity
Mar 1, 2006